A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, September 29, 2022 | 3 - 4:15 p.m. ET | Virtual Beginning September 2022, NHGRI will host a new seminar series based on its Genomic Innovator Award Program, which supports innovative work by early-career genomics investigators who are part of consortia or other team-science efforts. Each seminar will feature an early-career researcher and an established […]
A platform approach to develop and deploy CRISPR-Cas based experimental therapies for inborn errors of immunity in an academic/nonprofit setting Thursday, February 8 | 2-3 p.m. ET | Bryan Neurobiology Research Building, Rm 103 Speaker: Fyodor Urnov, PhD Professor of Molecular & Cellular Biology, University of California, Berkeley Director of Technology & Translation, Innovative Genomics […]
GMKB